Exemestane for breast cancer prevention: A critical shift?

Keyphrases

• Exemestane 100%
• Critical Shifts 100%
• Breast Cancer Prevention 100%
• High Risk 40%
• Postmenopausal Women 40%
• Obesity 20%
• Phase II Trial 20%
• Adverse Events 20%
• Risk Reduction 20%
• New Standards 20%
• Implications for Future 20%
• Placebo-controlled Randomized Trial 20%
• Data Maturity 20%
• Selective Estrogen Receptor Modulators 20%
• Risk-benefit Ratio 20%
• Chemoprevention 20%
• Invasive Breast Cancer 20%
• Alternative Dosing 20%
• Prevention Research 20%
• Aromatase Inhibitors 20%

Medicine and Dentistry

• Exemestane 100%
• Breast Cancer Prevention 100%
• Postmenopause 40%
• Breast Cancer 20%
• Biological Marker 20%
• Placebo 20%
• Arm 20%
• Randomized Controlled Trial 20%
• Adverse Event 20%
• Risk Reduction 20%
• Weakness 20%
• Chemoprophylaxis 20%
• Selective Estrogen Receptor Modulator 20%
• Aromatase Inhibitor 20%
• Phase III Trials 20%